{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,24]],"date-time":"2025-10-24T08:17:55Z","timestamp":1761293875564},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T00:00:00Z","timestamp":1549238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"abstract":"<jats:title>Abstract<\/jats:title><jats:p>The association between perioperative blood transfusion (PBT) with adverse oncological outcomes have been previously reported in multiple malignancies including RCC. Nevertheless, the importance of transfusion timing is still unclear. The primary purpose of this study is to appraise whether the receipt of intraoperative blood transfusion (BT) differ from postoperative BT in regards to cancer outcomes in renal cell carcinoma (RCC) patients treated with nephrectomy. Data on 1168 patients with RCC, who underwent radical or partial nephrectomy as primary therapy between 1988\u20132013 were analyzed. PBT was defined as transfusion of allogeneic red blood cells (RBC) during surgery or the postsurgical period. Survival was analyzed and compared using the Kaplan\u2013Meier method with the log-rank test. Of 1168 patients, 198 patients (16.9%) received a PBT. Including 117 intraoperative BT and 81 postoperative BT. Only 21 (10.6%) patients required both intraoperative and postoperative BT. On multivariate analyses, receipt of PBT was associated with significantly worse local disease recurrence (HR: 2.4; P\u2009=\u20090.017), metastatic progression (HR: 2.7; P\u2009=\u20090.005), cancer-specific mortality (HR: 3.5; P\u2009=\u20090.002) and all-cause mortality (HR: 2.1; P\u2009=\u20090.005). Nevertheless, postoperative BT was<jats:italic>not<\/jats:italic>independently associated with increased risk of local recurrence (p\u2009=\u20090.1), metastatic progression (P\u2009=\u20090.16) or kidney cancer death (P\u2009=\u20090.63), yet did significantly increase the risk of overall mortality (HR: 2.6; P\u2009=\u20090.004). In the current study, intraoperative transfusion of allogeneic RBC is associated with increased risks of cancer recurrence and mortality following nephrectomy.<\/jats:p>","DOI":"10.1038\/s41598-018-37691-4","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T11:04:09Z","timestamp":1549278249000},"update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Intraoperative but not postoperative blood transfusion adversely affect cancer recurrence and survival following nephrectomy for renal cell carcinoma"],"prefix":"10.1038","volume":"9","author":[{"given":"Yasmin","family":"Abu-Ghanem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zohar","family":"Dotan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dorit E.","family":"Zilberman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Issac","family":"Kaver","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob","family":"Ramon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,2,4]]},"reference":[{"key":"37691_CR1","doi-asserted-by":"publisher","unstructured":"Luan, H., Ye, F., Wu, L., Zhou, Y. & Jiang, J. Perioperative blood transfusion adversely affects prognosis after resection of lung cancer: a systematic review and a meta-analysis. BMC Surgery, https:\/\/doi.org\/10.1186\/1471-2482-14-34 (2014).","DOI":"10.1186\/1471-2482-14-34"},{"key":"37691_CR2","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1097\/SLA.0b013e31825b35d5","volume":"256","author":"AG Acheson","year":"2012","unstructured":"Acheson, A. G., Brookes, M. J. & Spahn, D. R. Effects of allogeneic red blood cell transfusions on clinical outcomes in patients undergoing colorectal cancer surgery: a systematic review and meta-analysis. Ann. Surg. 256, 235\u201344 (2012).","journal-title":"Ann. Surg."},{"key":"37691_CR3","doi-asserted-by":"publisher","first-page":"839","DOI":"10.1016\/j.eururo.2013.01.004","volume":"63","author":"BJ Linder","year":"2013","unstructured":"Linder, B. J. et al. The impact of perioperative blood transfusion on cancer recurrence and survival following radical cystectomy. Eur. Urol. 63, 839\u201345 (2013).","journal-title":"Eur. Urol."},{"key":"37691_CR4","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1080\/1561095031000135064","volume":"3","author":"W Mermershtain","year":"2003","unstructured":"Mermershtain, W., Eidelberg, I., Yusim, I., Ariad, S. & Kaneti, J. Perioperative Homologous Blood Transfusion and Survival in Patients with Surgically Treated Renal Cell Carcinoma. UroOncology 3, 23\u201325 (2003).","journal-title":"UroOncology"},{"key":"37691_CR5","doi-asserted-by":"publisher","first-page":"e173","DOI":"10.1016\/j.clgc.2014.12.006","volume":"13","author":"A Soubra","year":"2015","unstructured":"Soubra, A. et al. Effect of perioperative blood transfusion on mortality for major urologic malignancies. Clin. Genitourin. Cancer 13, e173\u201381 (2015).","journal-title":"Clin. Genitourin. Cancer"},{"key":"37691_CR6","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/bju.12535","volume":"114","author":"BJ Linder","year":"2014","unstructured":"Linder, B. J. et al. The impact of perioperative blood transfusion on survival after nephrectomy for non-metastatic renal cell carcinoma (RCC). BJU Int. 114, 368\u201374 (2014).","journal-title":"BJU Int."},{"key":"37691_CR7","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1093\/bja\/aes255","volume":"109","author":"LA Colvin","year":"2012","unstructured":"Colvin, L. A., Fallon, M. T. & Buggy, D. J. Cancer biology, analgesics, and anaesthetics: is there a link? Br. J. Anaesth. 109, 140\u20133 (2012).","journal-title":"Br. J. Anaesth."},{"key":"37691_CR8","first-page":"2239","volume":"33","author":"M Pesta","year":"2013","unstructured":"Pesta, M., Fichtl, J., Kulda, V., Topolcan, O. & Treska, V. Monitoring of circulating tumor cells in patients undergoing surgery for hepatic metastases from colorectal cancer. Anticancer Res. 33, 2239\u201343 (2013).","journal-title":"Anticancer Res."},{"key":"37691_CR9","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.1016\/j.eururo.2014.08.051","volume":"66","author":"EJ Abel","year":"2014","unstructured":"Abel, E. J. et al. Perioperative blood transfusion and radical cystectomy: does timing of transfusion affect bladder cancer mortality? Eur. Urol. 66, 1139\u201347 (2014).","journal-title":"Eur. Urol."},{"key":"37691_CR10","doi-asserted-by":"publisher","first-page":"562","DOI":"10.1016\/j.clgc.2015.04.009","volume":"13","author":"M Moschini","year":"2015","unstructured":"Moschini, M. et al. Effect of Allogeneic Intraoperative Blood Transfusion on Survival in Patients Treated With Radical Cystectomy for Nonmetastatic Bladder Cancer: Results From a Single High-Volume Institution. Clin. Genitourin. Cancer 13, 562\u2013567 (2015).","journal-title":"Clin. Genitourin. Cancer"},{"key":"37691_CR11","doi-asserted-by":"publisher","first-page":"469","DOI":"10.1016\/S0022-5347(01)69066-9","volume":"167","author":"IS GILL","year":"2002","unstructured":"GILL, I. S. et al. Laparoscopic partial nephrectomy for renal tumor: duplicating open surgical techniques. J. Urol. 167, 469\u2013476 (2002).","journal-title":"J. Urol."},{"key":"37691_CR12","first-page":"281","volume":"13","author":"SC Campbell","year":"1995","unstructured":"Campbell, S. C. & Novick, A. C. Surgical technique and morbidity of elective partial nephrectomy. Semin. Urol. Oncol. 13, 281\u20137 (1995).","journal-title":"Semin. Urol. Oncol."},{"key":"37691_CR13","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1016\/S0022-5347(05)66066-1","volume":"166","author":"RG Uzzo","year":"2001","unstructured":"Uzzo, R. G. & Novick, A. C. Nephron sparing surgery for renal tumors: indications, techniques, and outcomes. J. Urol. 166, 6\u201318 (2001).","journal-title":"J. Urol."},{"key":"37691_CR14","unstructured":"Ljungberg, B., Albiges, L., Bensalah, K., Bex, A. & Gilles, R. H. Guidelines on Renal Cell Carcinoma EAU. Eur. Assoc. Urol. Update. March 2017 (2017)."},{"key":"37691_CR15","doi-asserted-by":"publisher","first-page":"12.e15","DOI":"10.1016\/j.urolonc.2017.09.006","volume":"36","author":"Y Abu-Ghanem","year":"2018","unstructured":"Abu-Ghanem, Y., Zilberman, D. E., Dotan, Z., Kaver, I. & Ramon, J. Perioperative blood transfusion adversely affects prognosis after nephrectomy for renal cell carcinoma. Urol. Oncol. Semin. Orig. Investig. 36, 12.e15\u201312.e20 (2018).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"37691_CR16","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1111\/j.1423-0410.1998.tb05437.x","volume":"74","author":"MA Blajchman","year":"1998","unstructured":"Blajchman, M. A. Immunomodulatory Effects of Allogeneic Blood Transfusions: Clinical Manifestations and Mechanisms. Vox Sang. 74, 315\u2013319 (1998).","journal-title":"Vox Sang."},{"key":"37691_CR17","doi-asserted-by":"publisher","first-page":"690","DOI":"10.1093\/bja\/aet068","volume":"110","author":"JP Cata","year":"2013","unstructured":"Cata, J. P., Wang, H., Gottumukkala, V., Reuben, J. & Sessler, D. I. Inflammatory response, immunosuppression, and cancer recurrence after perioperative blood transfusions. Br. J. Anaesth. 110, 690\u2013701 (2013).","journal-title":"Br. J. Anaesth."},{"key":"37691_CR18","doi-asserted-by":"publisher","first-page":"1424","DOI":"10.1002\/bjs.9617","volume":"101","author":"A Ejaz","year":"2014","unstructured":"Ejaz, A., Spolverato, G., Kim, Y., Frank, S. M. & Pawlik, T. M. Variation in triggers and use of perioperative blood transfusion in major gastrointestinal surgery. Br. J. Surg. 101, 1424\u20131433 (2014).","journal-title":"Br. J. Surg."},{"key":"37691_CR19","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.blre.2007.07.003","volume":"21","author":"EC Vamvakas","year":"2007","unstructured":"Vamvakas, E. C. & Blajchman, M. A. Transfusion-related immunomodulation (TRIM): An update. Blood Rev. 21, 327\u2013348 (2007).","journal-title":"Blood Rev."},{"key":"37691_CR20","doi-asserted-by":"publisher","first-page":"931","DOI":"10.1016\/j.jamcollsurg.2008.11.019","volume":"208","author":"AC Bernard","year":"2009","unstructured":"Bernard, A. C., Davenport, D. L., Chang, P. K., Vaughan, T. B. & Zwischenberger, J. B. Intraoperative Transfusion of 1 U to 2 U Packed Red Blood Cells Is Associated with Increased 30-Day Mortality, Surgical-Site Infection, Pneumonia, and Sepsis in General Surgery Patients. J. Am. Coll. Surg. 208, 931\u2013937.e2 (2009).","journal-title":"J. Am. Coll. Surg."},{"key":"37691_CR21","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1097\/ALN.0b013e318255e550","volume":"117","author":"SM Frank","year":"2012","unstructured":"Frank, S. M. et al. Variability in blood and blood component utilization as assessed by an anesthesia information management system. Anesthesiology 117, 99\u2013106 (2012).","journal-title":"Anesthesiology"},{"key":"37691_CR22","doi-asserted-by":"publisher","first-page":"e64261","DOI":"10.1371\/journal.pone.0064261","volume":"8","author":"L Liu","year":"2013","unstructured":"Liu, L. et al. Perioperative allogeneic blood transfusion is associated with worse clinical outcomes for hepatocellular carcinoma: a meta-analysis. PLoS One 8, e64261 (2013).","journal-title":"PLoS One"},{"key":"37691_CR23","doi-asserted-by":"publisher","first-page":"4382","DOI":"10.1245\/s10434-015-4823-6","volume":"22","author":"MN Mavros","year":"2015","unstructured":"Mavros, M. N. et al. Perioperative Blood Transfusion and the Prognosis of Pancreatic Cancer Surgery: Systematic Review and Meta-analysis. Ann. Surg. Oncol. 22, 4382\u20134391 (2015).","journal-title":"Ann. Surg. Oncol."},{"key":"37691_CR24","doi-asserted-by":"publisher","first-page":"256.e7","DOI":"10.1016\/j.urolonc.2015.12.016","volume":"34","author":"M Moschini","year":"2016","unstructured":"Moschini, M. et al. Timing of blood transfusion and not ABO blood type is associated with survival in patients treated with radical cystectomy for nonmetastatic bladder cancer: Results from a single high-volume institution. Urol. Oncol. Semin. Orig. Investig. 34, 256.e7\u2013256.e13 (2016).","journal-title":"Urol. Oncol. Semin. Orig. Investig."},{"key":"37691_CR25","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/j.clgc.2017.01.001","volume":"15","author":"M Moschini","year":"2017","unstructured":"Moschini, M. et al. Impact of Intra- and Postoperative Blood Transfusion on the Incidence, Timing, and Pattern of Disease Recurrence After Radical Cystectomy. Clin. Genitourin. Cancer 15, e681\u2013e688 (2017).","journal-title":"Clin. Genitourin. Cancer"}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37691-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37691-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37691-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,7,14]],"date-time":"2024-07-14T14:37:06Z","timestamp":1720967826000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-018-37691-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,2,4]]},"references-count":25,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2019,12]]}},"alternative-id":["37691"],"URL":"https:\/\/doi.org\/10.1038\/s41598-018-37691-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,2,4]]},"assertion":[{"value":"27 June 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 December 2018","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"4 February 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing Interests"}}],"article-number":"1160"}}